MOVICOL(r) Flavour Free

Overview

EFFECTIVE RELIEF FROM CONSTIPATION WHICH WORKS BY REHYDRATING THE STOOL TO RESTORE COMFORTABLE BOWEL MOVEMENTS

MOVICOL is macrogol 3350 + electrolytes
Macrogol is a PEG -high molecular weight polymer which is non-toxic, pharmacologically inert, and virtually unabsorbed. The macrogol attracts and holds water in the bowel for effective stool softening. The electrolytes in MOVICOL help mitigate the possibility of electrolyte imbalance and dehydration.
MOVICOL has a 4 in 1 action
1. Hydrates and bulks
2. Softens
3. Triggers natural movement in the bowel
4. Lubricates the stool
MOVICOL is lactose free, gluten free, sucrose free
For effective relief from constipation and treatment of chronic constipation; treatment of medically diagnosed faecal impaction.

AUST R NUMBER:

AUST R 181834

Ingredients

CONTAINS:

Contains 187 mg of sodium and 26 mg of potassium.

INGREDIENTS:

Active ingredients and Quantities per sachet/per 125 mL after preparation
Macrogol 3350 13.125 g
Sodium bicarbonate 178.6 mg
Sodium chloride 350.8 mg
Potassium chloride 50.2 mg
Contains 187 mg of sodium and 26 mg of potassium.
Active ingredients and Quantities per sachet/per 125 mL after preparation
Macrogol 3350 13.125 g
Sodium bicarbonate 178.6 mg
Sodium chloride 350.8 mg
Potassium chloride 50.2 mg

Instructions

DOSAGE:

one sachet per 125mL of water

Storage

STORAGE TEMPERATURE:

Store below 30oC

Safety

PRODUCT WARNINGS:

Do not take MOVICOL Flavour Free if your doctor has told you that you have:
* an obstruction in your intestine (gut)
* a perforated gut wall
* severe inflammatory bowel disease, like ulcerative colitis, Crohn's disease, or toxic megacolon
* paralysis of the bowel
* an allergy to macrogol or any of the ingredients.

MOVICOL Flavour Free is for use in adults and children aged 12 years and over. The Movicol Junior range is available for children between 2 and 11 years of age.
The fluid content of MOVICOL
when re-constituted with water does not
replace regular fluid intake and adequate
fluid intake must be maintained.
Laxative products such as Movicol have the
potential to interact with other medications,
by altering their absorption. Close monitoring
of the effects of the medications may be
necessary when patient starts or stops
taking Movicol regularly. It is important that
the patient should discuss this with the
doctor.
If the patient is pregnant talk to the doctor
before taking Movicol.
If the patient needs to thicken fluids in order
to swallow them safely, Movicol may
counteract the effect of the thickener.

ONLINE MANDATORY STATEMENT:

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE

Country of Origin

Australia